Five new ventures secure the chance to be part of Babraham Research Campus - a leading location for early-stage life science start-ups
Cambridge, 12th June 2025: Five life science start-ups focused on the development of new technology, products and services to positively impact future healthcare have been selected to participate in Babraham Research Campus’ accelerator programme, Accelerate@Babraham.
Held annually, Accelerate@Babraham is now in its seventh year. Since its inception, the programme has supported 32 early-stage enterprises and earlier this year…
Extends capabilities of industry-leading PhysioMimix DILI assay for comparative studies between animal species and human
Generates deeper insights into inter-species differences to de-risk development pipelines and minimize animal testing
Cambridge, UK, 10 June 2025: CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two new animal microphysiological system (MPS) models that enhance translatability in preclinical drug safety and toxicology assessments to its Contract Research Services (CRS…
Wickman House: Premium Staff Accommodation in the Heart of North Cambridge198 Green End Road, Chesterton, Cambridge, CB4
In a city where demand for talent is matched only by the need for quality housing, Wickman House offers forward-thinking employers a strategic opportunity to secure accommodation for their workforce.
This brand-new, purpose-built Build to Rent development comprises nine high-quality apartments in the well-connected neighbourhood of Chesterton, just minutes from Cambridge Science Park, Cambridge Business Park, and St John’s Innovation Centre. It’s the perfect base for staff…
Global drug development consultancy Boyds has announced the appointment of Lisa Allenby as Associate Director, Regulatory Operations.
Lisa has more than 25 years’ experience in regulatory operations, having previously worked at DLRC Regulatory Consultancy and pharmaceutical company Mylan. She has extensive experience of managing major filings across the globe, as well as leading cross-functional meetings representing regulatory operations in the submissions management process.
Lisa also has experience working with SMEs on key projects with the Medicines and Healthcare products Regulatory…
Cambridge, UK – 10 June 2025: Microbiotica, a clinical-stage biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), announces that Dr Robert Tansley is appointed Chief Medical Officer with immediate effect.
Dr Tansley steps into the role at a key development stage for Microbiotica with its two lead programmes progressing through Phase 1 clinical trials in immuno-oncology (MB097 for advanced melanoma), and inflammatory bowel disease (MB310 for ulcerative colitis) with data read-outs anticipated this year.
Dr Robert Tansley…
Life Science Agency CLOK are proud to announce the opening of new high-tech offices situated between Sherwood Pines and Center Parcs. Designed to support innovation and collaboration, the state-of-the-art space offers ultra-fast connectivity and top-tier facilities. A premium working environment reflects the organisations commitment to excellence, providing a clean air, friendly environment that is surrounded by acres of greenspace. The new office is located with excellent transport links for both clients and team members, with free on-site parking and great local amenities, including…
London, June 5th 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully completed a search assignment for Melt&Marble and is pleased to announce the placement of Tue Hodal as its first Chief Technology Officer (CTO).Melt&Marble is a manufacturer of precision-fermented fats; the company has developed a proprietary technology designed to engineer yeast metabolism to produce tailored fats that meet specific functional and compositional requirements across various applications, including…
Read June eNews here
Featuring:
Back in Boston, But It’s No Tea Party For All At The Moment, by Tony Jones, CEO, One Nucleus
Key Reflections of the Boston Bootcamp 2025 by Alicia Gailliez, Business Development Manager, One Nucleus
Is There An App For That? by Tony Jones, CEO, One Nucleus
Connect with One Nucleus ar BIO and RESI Boston this June
Purchasing Scheme Update from Richard Dickinson, Chief Technical Specialist, One Nucleus
Is 2025 the Year the Cambridge-to-Cambridge Bridge Really Flourishes? Tony's Jones' article in the Business Weekly newspaper
#ONHelix25 Conference…
The May edition of our People Pathways newsletter is available to read here!
Featuring:
✅ One Nucleus upcoming courses
✅ Training Highlights
✅ Top 3 reasons why you should attend our upcoming Introduction to Managing Life Science Projects - a short and fun video by our trainer John Faulkes...
Earlier this month, the House of Lords passed the Precision Breeding Act which has opened up a new world of opportunity for researchers and food biotech companies at Norwich Research Park.
The Act allows for the gene editing of plants and crops in England, something Tropic, a food biotech company that has been based at Norwich Research Park for several years, is pioneering with crops grown in tropical regions of the world such as bananas and rice as well as closer to home with sugar beet.
Gene editing enables precise, targeted changes to plant DNA to make improved varieties that are resistant…